-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Verve Therapeutics, Inc. annual/quarterly Net Cash Provided by (Used in) Investing Activities history and growth rate from 2019 to 2024.
- Verve Therapeutics, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2024 was -$41.6M, a 370% decline year-over-year.
- Verve Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2024 was $74.9M, a 170% increase from 2023.
- Verve Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was $27.7M.
- Verve Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$156M, a 34.8% increase from 2021.
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)